Skip to main navigation Skip to search Skip to main content

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

Project Details

StatusFinished
Effective start/end date1/01/21 → 31/12/23

Funding

  • Institute of Health Carlos III (ISCIII): €123,420.00